Sequencing that scales with you

Our scalable sequencing capacity ensures that we can meet the current and future demands of any size company.

Solutions that support your operation

To grow your business, you need a partner you can trust—one that delivers reliable genomics data and respects client ownership of all data produced.

The Broad Institute conducts testing in accordance with CLIA/CAP standards to produce high-quality results. Data is transmitted securely to safeguard your ability to produce and commercialize innovative healthcare solutions.

High complexity testing

Clinical WGS and clinical WES
Additional assays: RNA-seq, liquid biopsy analysis, custom gene panels, molecular diagnostics, and more
Highly trained laboratory technicians and scientists

Commercial agreements

Business agreements and B2B services
Professional approach for client success

Scalable capacity

Proven ability to support high sample volumes
Infrastructure designed to support expansion

Sample compatibility

Multiple sample types and collection devices accepted
Small to large batch sizes accepted
We can develop a project plan that best suits your sample set

Data sharing

Clients retain ownership of data
Securely receive ready-to-use BAM and/or VCF files, pdf, or structured data
Data is in a format compatible with longitudinal studies and tertiary analysis programs